Skip to main content
logo
Boundless Bio, Inc. (BOLD)
NASDAQ: BOLD · Real-Time Price · USD
2.460
-0.020 (-0.81%)
Oct 30, 2026, 10:18 AM EDT - Market open

Boundless Bio Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
562765---
Market Cap Growth
71.22%-58.46%----
Enterprise Value
-17-41-102---
Last Close Price
2.481.202.90---

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PB Ratio
0.840.270.43---
P/TBV Ratio
0.860.270.43---

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
-0.500.320.020.080.00
Net Debt / Equity Ratio
-1.10-0.59-0.69-0.98-0.93-0.66
Net Debt / EBITDA Ratio
1.130.941.452.201.352.95
Net Debt / FCF Ratio
1.281.241.652.501.512.87
Quick Ratio
9.358.5818.7012.908.6318.89
Current Ratio
9.488.7418.9813.278.8019.28
Return on Equity (ROE)
-67.86%-46.69%-48.21%-52.93%-52.16%-
Return on Assets (ROA)
-32.77%-21.86%-27.23%-33.13%-30.48%-
Return on Capital Employed (ROCE)
-100.60%-44.00%-37.00%-45.50%-67.20%-23.00%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-116.11%-216.66%-101.08%---
FCF Yield
-100.57%-175.75%-98.01%---
Buyback Yield / Dilution
-0.37%-31.65%-1296.71%-10.77%-27.56%-
SEC Filings: 10-K · 10-Q